Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection

Virology

Volumn 435, Issue 2, 2013, Pages 425-432

  Jackson, Robert ^a,b   Togtema, Melissa ^a,b   Zehbe, Ingeborg ^a,b  

^a Thunder Bay Regional Research Institute   (Canada)

^b LAKEHEAD UNIVERSITY   (Canada)

Author keywords

4C6 antibody; CaSki; E6 oncoprotein; Human papillomavirus type 16 (HPV16); Immunocytochemistry; Protein expression; SiHa; Subcellular localization

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4C6; PROTEIN E6; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIBODIES, MONOCLONAL; CARCINOMA; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; SUBCELLULAR FRACTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 84871684688     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.09.032     Document Type: Article

References (28)

1. Androphy E.J., Hubbert N.L., Schiller J.T., Lowy D.R. Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J. 1987, 6:989-992.
2. Auersperg N. Long-term cultivation of hypodiploid human tumor cells. J. Natl. Cancer Inst. 1964, 32:135-163.
3. Baker C.C., Phelps W.C., Lindgren V., Braun M.J., Gonda M.A., Howley P.M. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 1987, 61:962-971.
4. Banks L., Spence P., Androphy E., Hubbert N., Matlashewski G., Murray A., Crawford L. Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas. J. Gen. Virol. 1987, 68(5):1351-1359.
5. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006, 7:R100.
6. Choulier L., Orfanoudakis G., Robinson P., Laune D., Ben Khalifa M., Granier C., Weiss E., Altschuh D. Comparative properties of two peptide-antibody interactions as deduced from epitope delineation. J. Immunol. Methods 2002, 259:77-86.
7. Courtĉte J., Sibler A.P., Zeder-Lutz G., Dalkara D., Oulad-Abdelghani M., Zuber G., Weiss E. Suppression of cervical carcinoma cell growth by intracytoplasmic codelivery of anti-oncoprotein E6 antibody and small interfering RNA. Mol. Cancer Ther. 2007, 6:1728-1735.
8. DeCarlo C.A., Escott N.G., Werner J., Robinson K., Lambert P.F., Law R.D., Zehbe I. Gene expression analysis of interferon κ in laser capture microdissected cervical epithelium. Anal. Biochem. 2008, 381:59-66.
9. Friedl F., Kimura I., Osato T., Ito Y. Studies on a new human cell line (SiHa) derived from carcinoma of uterus I. Its establishment and morphology. Proc. Soc. Exp. Biol. Med. 1970, 135:543-545.
10. Giovane C., Trave G., Briones A., Lutz Y., Wasylyk B., Weiss E. Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53. J. Mol. Recognition 1999, 12:141-152.
11. Grossman S.R., Mora R., Laimins L.A. Intracellular localization and DNA-binding properties of human papillomavirus type 18 E6 protein expressed with a baculovirus vector. J. Virol. 1989, 63:366-374.
12. Kamentsky L., Jones T.R., Fraser A., Bray M.A., Logan D.J., Madden K.L., Ljosa V., Rueden C., Eliceiri K.W., Carpenter A.E. Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 2011, 27:1179-1180.
13. Kim K.H., Yoon D.J., Moon Y.A., Kim Y.S. Expression and localization of human papillomavirus type 16 E6 and E7 open reading frame proteins in human epidermal keratinocyte. Yonsei Med. J. 1994, 35:1-9.
14. Kumar A., Zhao Y., Meng G., Zeng M., Srinivasan S., Delmolino L.M., Gao Q., Dimri G., Weber G.F., Wazer D.E., Band H., Band V. Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol. Cell Biol. 2002, 22:5801-5812.
15. Lagrange M., Charbonnier S., Orfanoudakis G., Robinson P., Zanier K., Masson M., Lutz Y., Trave G., Weiss E., Deryckere F. Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6. J. Gen. Virol. 2005, 86:1001-1007.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta] CT method. Methods 2001, 25:402-408.
17. Mantovani F., Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20:7874-7887.
18. Masson M., Hindelang C., Sibler A.P., Schwalbach G., Trave G., Weiss E. Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells. J. Gen. Virol. 2003, 84:2099-2104.
19. Matlashewski G., Banks L., Wu-Liao J., Spence P., Pim D., Crawford L. The expression of human papillomavirus type 18 E6 protein in bacteria and the production of anti-E6 antibodies. J. Gen. Virol. 1986, 67(9):1909-1916.
20. Park D.S., Selvey L.A., Kelsall S.R., Frazer I.H. Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J. Virol. Methods 1993, 45:303-318.
21. Pattillo R.A., Hussa R.O., Story M.T., Ruckert A.C., Shalaby M.R., Mattingly R.F. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 1977, 196:1456-1458.
22. R Development Core Team, 2008. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 3-900051-07-0, URL http://www.R-project.org.
23. Roberts I., Ng G., Foster N., Stanley M., Herdman M.T., Pett M.R., Teschendorff A., Coleman N. Critical evaluation of HPV16 gene copy number quantification by SYBR green PCR. BMC Biotechnol. 2008, 8:57.
24. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
25. Sellors J.W., Schweizer J.G., Lu P.S., Liu B., Weigl B.H., Cui J.F., Peck R.B., Lewis K., Lim J., Howard M., Mahoney C.W., McAllister L., Berard-Bergery M., Bry C., Labiad Y.A., Li H., Liu L., Silver J., Chen W., Qiao Y.L. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6. J. Low Genit. Tract Dis. 2011, 15:169-176.
26. Wlazlo A.P., Giles-Davis W., Clements A., Struble G., Marmorstein R., Ertl H.C. Generation and characterization of monoclonal antibodies against the E6 and E7 oncoproteins of HPV. Hybridoma 2001, 20:257-263.
27. Yee C., Krishnan-Hewlett I., Baker C.C., Schlegel R., Howley P.M. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am. J. Pathol. 1985, 119:361-366.
28. Zehbe I., Richard C., DeCarlo C.A., Shai A., Lambert P.F., Lichtig H., Tommasino M., Sherman L. Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis. Virology 2009, 383:69-77.